FFCFC/FCF Customer Becomes Inaugural NADCO SBA 504 Borrower Hall of Fame Inductee
TALLAHASSEE, Fla.–(BUSINESS WIRE)–Florida First Capital Finance Corporation/First Capital Finance (FFCFC/FCF) is proud to announce its…
Month: April 2022
TransPerfect Selected by Finnair as Main Language Services Provider
Major Nordic Airline Chooses GlobalLink Technology to Manage Multilingual Content NEW YORK & VANTAA, Finland–(BUSINESS…
KBRA Assigns Preliminary Ratings to RCKT Mortgage Trust 2022-3 (RCKT 2022-3)
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to 47 classes of mortgage-backed notes from RCKT Mortgage…
K2 Scientific Announces Signing of Merchandising Deal with Blood Centers of America
CHARLOTTE, N.C.–(BUSINESS WIRE)–K2 Scientific, a leader in the medical cold storage industry, is announcing their…
OneDigital Hires Marcia Calleja-Matsko as Chief Information Officer
Calleja-Matsko joins OneDigital’s executive team to grow the IT organization and support product development ATLANTA–(BUSINESS…
CORRECTING and REPLACING PHOTO Palladius Capital Management Hires Nicholas Maupin as Director, Investments
AUSTIN, Texas–(BUSINESS WIRE)–Please replace the photo with the accompanying corrected photo. The release reads: PALLADIUS…
Craig DeSanto Assumes New York Life Chief Executive Officer Position
DeSanto will serve as 19th Chief Executive in company’s 177-year history NEW YORK–(BUSINESS WIRE)–New York…
Liberty Latin America Appoints Aamir Hussain as Chief Technology and Product Officer
DENVER–(BUSINESS WIRE)–Liberty Latin America Ltd. (“Liberty Latin America” or “LLA”) (NASDAQ: LILA and LILAK, OTC…
Senti Bio to Present at Chardan’s 6th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
SOUTH SAN FRANCISCO, Calif., April 18, 2022 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (“Senti Bio”),…
Castellum, Inc. Closes on the Acquisition of Lexington Solutions Group
Castellum, Inc. Closes on the Acquisition of Lexington Solutions Group Castellum, Inc. (OTC: ONOV) announces…
Entasis Therapeutics Presents SUL-DUR Topline Data from Phase 3 ATTACK Trial at ECCMID 2022 Conference
WALTHAM, Mass., April 18, 2022 (GLOBE NEWSWIRE) — Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX), a…
Heat Biologics’ Scorpion Subsidiary Announces Planned Development of New Kansas Commercial/Biodefense Biomanufacturing Facility
500,000+ square foot facility to support commercial-scale biomanufacturing Livestreaming ceremony with Governor Laura Kelly Live from…
AmoyDx Enters into Master Collaboration Agreement with AstraZeneca for Multiple Companion Diagnostics Programs in China, EU and Japan
SHANGHAI, China, April 18, 2022 (GLOBE NEWSWIRE) — Amoy Diagnostics Co., Ltd (AmoyDx), a China…
Aadi Bioscience to Participate at the Jefferies “Biotech on the Bay” Summit
LOS ANGELES, April 18, 2022 (GLOBE NEWSWIRE) — Aadi Bioscience, Inc. (“Aadi”) (NASDAQ: AADI), a…
Taysha Gene Therapies to Participate in Upcoming Chardan Genetic Medicines and Cell Therapy Manufacturing Summit
Chief Executive Officer, Chief Technical Officer, Chief Medical Officer and Head of Research and Development…
Fuisz Pharma LLC Announces Patent Issuance for its Non-Invasive Urological Device to Mitigate the Symptoms of Benign Prostate Hyperplasia (BPH)
Williamson County, TN, April 18, 2022 (GLOBE NEWSWIRE) — Fuisz Pharma LLC, an affiliate of…
Kinnate Biopharma Inc. Announces First Patient Dosed in Phase 1 Clinical Trial of its FGFR Inhibitor Product Candidate, KIN-3248
SAN FRANCISCO and SAN DIEGO, April 18, 2022 (GLOBE NEWSWIRE) — Kinnate Biopharma Inc. (Nasdaq:…
Aquestive Therapeutics to Report First Quarter 2022 Financial Results and Recent Business Highlights on May 3 and Host Conference Call on May 4 at 8:00 a.m. ET
WARREN, N.J., April 18, 2022 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical…
Ocugen, Inc. to Commercialize COVAXIN™ in Mexico, Rights Now Encompassing All of North America
• Ocugen responsible for commercialization of COVAXIN™ in Mexico • COVAXIN™, already authorized for emergency use…
ContraFect Announces Multiple Presentations of New Data Demonstrating the Potential of Its Direct Lytic Agents (DLAs) to Address Antimicrobial Resistance at the 32nd Annual ECCMID Meeting
YONKERS, N.Y., April 18, 2022 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage…